Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
A quick consultation helps us tailor the best plan for your energy and weight management goals
Visits are calm and efficient
always consult a provider
This ensures the medicine remains effective throughout its shelf life and prevents any potential degradation
NAD+ therapy (injections/IVs) excels, boosting levels, mitochondrial function, and energy.[20][21] Clinical evidence shows improvements in fatigue and metabolic markers, with some studies reporting enhanced quality of life
US$ 23.25
US$ 27.51
US$ 27.55
US$ 26.39
US$ 29.10
US$ 22.58
